ВАЖНО! Правила приравнивания журналов, входящих в международные базы данных к журналам перечня ВАК.
Ответ на официальный запрос в ВАК журнала Кардиология.

Preview

Hypertensive Crisis in the Elderly Patients

https://doi.org/10.18087/cardio.2020.5.n1121

Abstract

A hypertensive crisis is a sudden increase in blood pressure (BP) to an individually high level associated with clinical symptoms and target organ damage, in which BP must be reduced immediately. Since 2018 in Europe and since 2020 in Russia, an uncomplicated hypertensive crisis is recommended to be considered as a part of malignant (uncontrolled) arterial hypertension. The clinical picture of increased BP in elderly patients is characterized by nonspecific symptoms even in target organ damage. Management of this group of patients requires a physician to know the patient’s comorbidities and the drugs taken on a regular basis to minimize development of side effects of the administered drugs and their undesirable interaction with the chronic therapy.

About the Authors

O. N. Tkacheva
Russian Clinical and Research Center of Gerontology, N. I. Pirogov Russian National Medical University, Moscow, Russia
Russian Federation
Professor, MD, PhD, Director of the Russian Clinical and Research Center of Gerontology, Pirogov’s Russian National Research Medical University.


Yu. V. Kotovskaya
Russian Clinical and Research Center of Gerontology, N. I. Pirogov Russian National Medical University, Moscow, Russia
Russian Federation

Professor, MD, PhD, Deputy Director of the Russian Clinical and Research Center of Gerontology, Head of the Laboratory of Cardiovascular Ageing, Pirogov’s Russian National Research Medical University.



K. A. Eruslanova
Russian Clinical and Research Center of Gerontology, N. I. Pirogov Russian National Medical University, Moscow, Russia
Russian Federation

MD, MSc, Researcher, Laboratory of  С Сardiovascular AgingRussian Clinical and Research Center of Gerontology, Pirogov’s Russian National Research Medical University.



References

1. World Health Organization. A global brief of hypertension. Silent killer, global public health crisis. World health day. 2013. [Document number : WHO/DCO/WHD/2013.2. Av. at: http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension.pdf]

2. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive Urgencies and Emergencies: Prevalence and Clinical Presentation. Hypertension. 1996;27(1):144–7. DOI: 10.1161/01.HYP.27.1.144

3. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018;39(33):3021–104. DOI: 10.1093/eurheartj/ehy339

4. Patel KK, Young L, Howell EH, Hu B, Rutecki G, Thomas G et al. Characteristics and Outcomes of Patients Presenting With Hypertensive Urgency in the Office Setting. JAMA Internal Medicine. 2016;176(7):981–8. DOI: 10.1001/jamainternmed.2016.1509

5. Ministry of Health of Russian Federation. Clinical guidelines. Arterial hypertension in adults. KR62. 2020.

6. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138(17):e484–594. DOI: 10.1161/CIR.0000000000000596

7. Lip GY, Beevers M, Beevers G. The failure of malignant hypertension to decline: a survey of 24 years’ experience in a multiracial population in England. Journal of Hypertension. 1994;12(11):1297–305. PMID: 7868878

8. Marik PE, Varon J. Hypertensive Crises: challenges and management. Chest. 2007;131(6):1949–62. DOI: 10.1378/chest.06-2490

9. Chobanian AV. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report. JAMA. 2003;289(19):2560–72. DOI: 10.1001/jama.289.19.2560

10. Lionakis N, Mendrinos D, Sanidas E, Favatas G, Georgopoulou M. Hypertension in the elderly. World Journal of Cardiology. 2012;4(5):135–47. DOI: 10.4330/wjc.v4.i5.135

11. Dharmashankar K, Widlansky ME. Vascular Endothelial Function and Hypertension: Insights and Directions. Current Hypertension Reports. 2010;12(6):448–55. DOI: 10.1007/s11906-010-0150-2

12. Varon J. Treatment of Acute Severe Hypertension: Current and Newer Agents. Drugs. 2008;68(3):283–97. DOI: 10.2165/00003495-200868030-00003

13. Singh M. Hypertensive crisis-pathophysiology, initial evaluation, and management. Journal of Indian College of Cardiology. 2011;1(1):36– 9. [Av. at: https://ru.scribd.com/document/402492083/patofisiologi-krisis-hipertensi]

14. Cowley AW, Lohmeier TE. Changes in renal vascular sensitivity and arterial pressure associated with sodium intake during long-term intrarenal norepinephrine infusion in dogs. Hypertension. 1979;1(6):549– 58. DOI: 10.1161/01.HYP.1.6.549

15. Pinna G, Pascale C, Fornengo P, Arras S, Piras C, Panzarasa P et al. Hospital Admissions for Hypertensive Crisis in the Emergency Departments: A Large Multicenter Italian Study. PLoS ONE. 2014;9(4):e93542. DOI: 10.1371/journal.pone.0093542

16. Elliott WJ. Clinical Features in the Management of Selected Hypertensive Emergencies. Progress in Cardiovascular Diseases. 2006;48(5):316–25. DOI: 10.1016/j.pcad.2006.02.004

17. Tulman DB, Stawicki SPA, Papadimos TJ, Murphy CV, Bergese SD. Advances in management of acute hypertension: a concise review. Discovery Medicine. 2012;13(72):375–83. PMID: 22642919

18. Muiesan ML, Salvetti M, Amadoro V, di Somma S, Perlini S, Semplicini A et al. An update on hypertensive emergencies and urgencies: Journal of Cardiovascular Medicine. 2015;16(5):372–82. DOI: 10.2459/JCM.0000000000000223

19. Li JZ, Eagle KA, Vaishnava P. Hypertensive and Acute Aortic Syndromes. Cardiology Clinics. 2013;31(4):493–501. DOI: 10.1016/j.ccl.2013.07.011

20. Gupta P, Gupta H, Khoynezhad A. Hypertensive Emergency in Aortic Dissection and Thoracic Aortic Aneurysm – A Review of Management. Pharmaceuticals. 2009;2(3):66–76. DOI: 10.3390/ph2030066

21. Bath PM, Krishnan K. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database of Systematic Reviews. 2014;10:CD000039. DOI: 10.1002/14651858.CD000039.pub3

22. Butcher KS, Jeerakathil T, Hill M, Demchuk AM, Dowlatshahi D, Coutts SB et al. The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial. Stroke. 2013;44(3):620–6. DOI: 10.1161/STROKEAHA.111.000188

23. Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C et al. Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage. New England Journal of Medicine. 2013;368(25):2355– 65. DOI: 10.1056/NEJMoa1214609

24. Tereshchenko S.N., Arutyunov G.P., Galyavich A.S., Gaponova N.I., Gilyarevsky S.R., Duplyakov D.V. et al. Emergency care in a sudden individually significant blood pressure increase without clinically overt target organ damage: rationale for captopril use. Expert Council opinion. Russian Journal of Cardiology. 2020;25(2):103–10. DOI: 10.15829/1560-4071-2020-2-3748

25. Peixoto AJ. Acute Severe Hypertension. New England Journal of Medicine. 2019;381(19):1843–52. DOI: 10.1056/NEJMcp1901117

26. Nedogoda S.V., Kobalava Zh.D., Konradi A.O. Algorithm of treatment of patients with atrial hypertension and hypertensive crisis. Russian cardiology society. 2019.

27. By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society. 2015;63(11):2227–46. DOI: 10.1111/jgs.13702

28. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276(16):1328– 31. PMID: 8861992

29. Varon J, Marik PE. Clinical review: the management of hypertensive crises. Critical Care. 2003;7(5):374–84. DOI: 10.1186/cc2351

30. Weimann H-J, Rudolph M. Clinical Pharmacokinetics of Moxonidine. Journal of Cardiovascular Pharmacology. 1992;20(Suppl 4):S37–41. DOI: 10.1097/00005344-199220004-00008

31. Vallerand AH, Sanoski CA, Deglin JH. Davis’s drug guide for nurses. Fourteenth ed. -Philadelphia: F. A. Davis Company;2015. - 1489 p. ISBN 978-0-8036-4085-6

32. Duchin KL, McKinstry DN, Cohen AI, Migdalof BH. Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular Diseases: Clinical Pharmacokinetics. 1988;14(4):241–59. DOI: 10.2165/00003088-198814040-00002

33. Kazerani H, Hajimoradi B, Amini A, Naseri MH, Moharamzad Y. Clinical efficacy of sublingual captopril in the treatment of hypertensive urgency. Singapore Medical Journal. 2009;50(4):400–2. PMID: 19421685

34. Fumagalli C, Maurizi N, Marchionni N, Fornasari D. β-blockers: Their new life from hypertension to cancer and migraine. Pharmacological Research. 2020;151:104587. DOI: 10.1016/j.phrs.2019.104587

35. Grassi G. Metoprolol in the treatment of cardiovascular disease: a critical reappraisal. Current Medical Research and Opinion. 2018;34(9):1635–43. DOI: 10.1080/03007995.2018.1479245

36. The American Society of Health-System Pharmacists. Propranolol hydrochloride. 2015. [Av. at: https://www.drugs.com/monograph/procainamide-hydrochloride.html]

37. Tschollar W, Belz GG. Sublingual captopril in hypertensive crisis. The Lancet. 1985;326(8445):34–5. DOI: 10.1016/S0140-6736(85)90073-X

38. Pose Reino A, González-Juanatey JR, Fernández Velo JL, Amaro Cendón A, Bugallo Paz L, Gil de la Peña M. Sublingual enalapril in hypertensive crisis. A preliminary study. Anales De Medicina Interna. 1989;6(8):421–3. PMID: 2562344

39. Gokel Y, Satar S, Paydas S. A Comparison of the Effectiveness of Sublingual Losartan, Sublingual Captopril and Sublingual Nifedipine in Hypertensive Urgency. Turkish Journal of Medical Sciences. 1999;29:655–60. [Av. at: https://www.researchgate.net/publication/296543224_A_comparison_of_the_effectiveness_of_sublingual_Losartan_sublingual_captopril_and_sublingual_nifedipine_ in_hypertensive_urgency]

40. Gemici K, Karakoç Y, Ersoy A, Baran I, Güllülü S, Cordan J. A comparison of safety and efficacy of sublingual captopril with sublingual nifedipine in hypertensive crisis. International Journal of Angiology. 2011;8(3):147–9. DOI: 10.1007/BF01616442

41. Divakaran S, Loscalzo J. The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics. Journal of the American College of Cardiology. 2017;70(19):2393–410. DOI: 10.1016/j.jacc.2017.09.1064

42. Marik PE, Rivera R. Hypertensive emergencies: an update. Current Opinion in Critical Care. 2011;17(6):569–80. DOI: 10.1097/MCC.0b013e32834cd31d

43. Ranadive SM, Eugene AR, Dillon G, Nicholson WT, Joyner MJ. Comparison of the vasodilatory effects of sodium nitroprusside vs. nitroglycerin. Journal of Applied Physiology. 2017;123(2):402–6. DOI: 10.1152/japplphysiol.00167.2017

44. Varon J, Marik PE. The Diagnosis and Management of Hypertensive Crises. Chest. 2000;118(1):214–27. DOI: 10.1378/chest.118.1.214

45. Sarafidis PA, Georgianos PI, Malindretos P, Liakopoulos V. Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents. Expert Opinion on Investigational Drugs. 2012;21(8):1089–106. DOI: 10.1517/13543784.2012.693477

46. Nightingale SL. From the Food and Drug Administration. JAMA. 1991;265(7):847. PMID: 1899454

47. Wood M, Hyman S, Wood AJ. A clinical study of sensitivity to sodium nitroprusside during controlled hypotensive anesthesia in young and elderly patients. Anesthesia and Analgesia. 1987;66(2):132–6. PMID: 3028217

48. Aronson S, Dyke CM, Stierer KA, Levy JH, Cheung AT, Lumb PD et al. The ECLIPSE Trials: Comparative Studies of Clevidipine to Nitroglycerin, Sodium Nitroprusside, and Nicardipine for Acute Hypertension Treatment in Cardiac Surgery Patients. Anesthesia & Analgesia. 2008;107(4):1110–21. DOI: 10.1213/ane.0b013e31818240db

49. Pongpanich P, Pitakpaiboonkul P, Takkavatakarn K, Praditpornsilpa K, Eiam-Ong S, Susantitaphong P. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis. International Urology and Nephrology. 2018;50(12):2261–78. DOI: 10.1007/s11255-018-1991-x

50. Dowd FJ, Johnson BS, Mariotti AJ. Pharmacology and therapeutics for dentistry. Elsevier Health Sciences;2017. - 864 p. ISBN 978-0-323-39307-2

51. Michael RK, Ralph EC, Arden WF, Barbara MK. Pharmacokinetics of orally administered furosemide. Clinical Pharmacology & Therapeutics. 1974;15(2):178–86. DOI: 10.1002/cpt1974152178

52. Alijotas-Reig J, Bove-Farre I, de Cabo-Frances F, Angles-Coll R. Effectiveness and safety of prehospital urapidil for hypertensive emergencies. The American Journal of Emergency Medicine. 2001;19(2):130– 3. DOI: 10.1053/ajem.2001.20008

53. Yang W, Zhou Y-J, Fu Y, Qin J, Qin S, Chen X-M et al. Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial. Yonsei Medical Journal. 2017;58(1):105–13. DOI: 10.3349/ymj.2017.58.1.105

54.


Review

For citations:


Tkacheva O.N., Kotovskaya Yu.V., Eruslanova K.A. Hypertensive Crisis in the Elderly Patients. Kardiologiia. 2020;60(5):128–135. (In Russ.) https://doi.org/10.18087/cardio.2020.5.n1121

Views: 5958


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0022-9040 (Print)
ISSN 2412-5660 (Online)